131
Participants
Start Date
November 30, 2006
Primary Completion Date
October 31, 2008
Study Completion Date
March 31, 2009
hMG-HP
hMG + GnRH antagonist
Investigational site, Barcelona
Investigational site, Ciudad Real
Investigational site, Girona
Investigational site, La Rioja
Investigational site, Navarra
Investigational site, Reus
Investigational site, Valladolid
Lead Sponsor
Ferring SAU
INDUSTRY
Ferring Pharmaceuticals
INDUSTRY